Future Outlook: The Intersection of Stem Cells and Gene Editing
As we look toward the 2030s, the "ultimate" use of cord blood may not be a simple transplant, but a "gene-edited" therapy. The rise of CRISPR technology allows scientists to precisely edit the DNA within a cell. If a child banks their cord blood and is later diagnosed with a genetic disorder, scientists could potentially "thaw" the cells, fix the genetic mutation in the lab, and then infuse the...
0 Comentários 0 Compartilhamentos 177 Visualizações 0 Anterior
Patrocinado